Category: Drug Studies for the Heart

Start Date: 06/07/2012

Tests the effect of varenicline (Champix™), a drug used to help people quit smoking, in patients who have suffered a heart attack. Varenicline has been recently shown to increase the number of otherwise healthy people who quit smoking compared to placebo (sugar pill). Although varenicline has been shown to reduce smoking in healthy populations, its effectiveness in patients recovering from a heart attack is unknown

Principal Investigator: Daniel Cassavar, MD, FACC

Contact the research coordinator: Jennifer Galliers, RN